Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats - PubMed (original) (raw)
. 2011 Sep 30;667(1-3):258-64.
doi: 10.1016/j.ejphar.2011.05.026. Epub 2011 May 27.
Affiliations
- PMID: 21640096
- DOI: 10.1016/j.ejphar.2011.05.026
Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats
Siddhartha R Bhatt et al. Eur J Pharmacol. 2011.
Abstract
Endothelial dysfunction is a hallmark of hypertension and vascular oxidative stress can contribute to endothelial dysfunction and hypertension development. Resveratrol is an antioxidant polyphenol which improves endothelium dependent relaxation, the mechanisms of which are unknown. Also, the role of resveratrol in hypertension remains to be established. The purpose of this study was to investigate the mechanisms of resveratrol induced improvement of endothelial function and establish its role in hypertension. SHR and WKY rats, 3-4 weeks old, were treated with resveratrol in drinking water for 10 weeks, untreated SHR and WKY rats served as controls. At the end of the treatment, control SHR exhibited increased blood pressure, oxidative stress and attenuated endothelium dependent relaxation in comparison to WKY rats. The impaired endothelium function in SHR was associated with lower nitrite/nitrate levels, elevated nitrotyrosine content and eNOS uncoupling. Resveratrol treatment attenuated hypertension development in SHR as indicated by lower blood pressure in resveratrol treated SHR (SHR-R) compared to control SHR. SHR-R also exhibited reduced H(2)O(2) content and elevated superoxide dismutase activity. Resveratrol treatment normalized endothelium dependent vasorelaxation in SHR. In parallel, resveratrol restored nitrite/nitrate levels and normalized nitrotyrosine content in SHR. SHR exhibited increased l-arginine dependent superoxide production which was blocked by NOS inhibitor l-NNA, suggesting eNOS uncoupling. eNOS uncoupling was prevented by resveratrol treatment. In conclusion, early treatment with resveratrol lowers oxidative stress, preserves endothelial function and attenuates development of hypertension in SHR. More importantly, prevention of eNOS uncoupling and NO scavenging could represent novel mechanisms for resveratrol-mediated antihypertensive effects.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
- Chronic administration of genistein improves endothelial dysfunction in spontaneously hypertensive rats: involvement of eNOS, caveolin and calmodulin expression and NADPH oxidase activity.
Vera R, Sánchez M, Galisteo M, Villar IC, Jimenez R, Zarzuelo A, Pérez-Vizcaíno F, Duarte J. Vera R, et al. Clin Sci (Lond). 2007 Feb;112(3):183-91. doi: 10.1042/CS20060185. Clin Sci (Lond). 2007. PMID: 17007611 - Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats.
Rush JW, Quadrilatero J, Levy AS, Ford RJ. Rush JW, et al. Exp Biol Med (Maywood). 2007 Jun;232(6):814-22. Exp Biol Med (Maywood). 2007. PMID: 17526774 - Resveratrol and endothelial nitric oxide.
Xia N, Förstermann U, Li H. Xia N, et al. Molecules. 2014 Oct 9;19(10):16102-21. doi: 10.3390/molecules191016102. Molecules. 2014. PMID: 25302702 Free PMC article. Review. - Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension.
Li Q, Youn JY, Cai H. Li Q, et al. J Hypertens. 2015 Jun;33(6):1128-36. doi: 10.1097/HJH.0000000000000587. J Hypertens. 2015. PMID: 25882860 Free PMC article. Review.
Cited by
- Antioxidant and Vasodilator Activity of Ugni molinae Turcz. (Murtilla) and Its Modulatory Mechanism in Hypotensive Response.
Jofré I, Pezoa C, Cuevas M, Scheuermann E, Freires IA, Rosalen PL, de Alencar SM, Romero F. Jofré I, et al. Oxid Med Cell Longev. 2016;2016:6513416. doi: 10.1155/2016/6513416. Epub 2016 Sep 4. Oxid Med Cell Longev. 2016. PMID: 27688827 Free PMC article. - Triggers for the Nrf2/ARE Signaling Pathway and Its Nutritional Regulation: Potential Therapeutic Applications of Ulcerative Colitis.
Liu H, Johnston LJ, Wang F, Ma X. Liu H, et al. Int J Mol Sci. 2021 Oct 22;22(21):11411. doi: 10.3390/ijms222111411. Int J Mol Sci. 2021. PMID: 34768841 Free PMC article. Review. - Resveratrol affects histone 3 lysine 27 methylation of vessels and blood biomarkers in DOCA salt-induced hypertension.
Han S, Uludag MO, Usanmaz SE, Ayaloglu-Butun F, Akcali KC, Demirel-Yilmaz E. Han S, et al. Mol Biol Rep. 2015 Jan;42(1):35-42. doi: 10.1007/s11033-014-3737-x. Epub 2014 Sep 19. Mol Biol Rep. 2015. PMID: 25234650 - Resveratrol did not alter blood pressure in rats with nitric oxide synthase-inhibited hypertension.
Aydin M, Gungor B, Akdur AS, Aksulu HE, Silan C, Susam I, Cabuk AK, Cabuk G. Aydin M, et al. Cardiovasc J Afr. 2017 May/Jun;28(3):141-146. doi: 10.5830/CVJA-2016-069. Cardiovasc J Afr. 2017. PMID: 28759085 Free PMC article. - Systemic treatment with resveratrol reduces the progression of experimental periodontitis and arthritis in rats.
Corrêa MG, Pires PR, Ribeiro FV, Pimentel SP, Cirano FR, Napimoga MH, Casati MZ, Casarin RCV. Corrêa MG, et al. PLoS One. 2018 Oct 3;13(10):e0204414. doi: 10.1371/journal.pone.0204414. eCollection 2018. PLoS One. 2018. PMID: 30281626 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical